Drug intelligence / Profile preview

juanbi

Development stage
Unknown
Lead developer
Golden Flower Chinese Herbs
Administration
Oral
01

Overview

Juanbi is a traditional Chinese medicine (TCM) formula used primarily for the treatment of musculoskeletal pain and inflammatory conditions such as rheumatoid arthritis and osteoarthritis. The canonical form "Juanbi" refers to a family of related herbal formulas including "Juan Bi Tang" (Remitting Bi Decoction), "Juanbi Pill," and commercial products like "Juan Bi Formula." These formulas are designed to remove wind-dampness, disperse cold, eliminate joint painful obstruction, circulate Qi and blood, and relieve painful stasis according to TCM principles[1][2][5][7]. Modern pharmacological studies suggest that the mechanism involves inhibition of key inflammatory pathways such as activator protein-1 (AP-1) and nuclear factor kappa B (NF-κB), reduction of pro-inflammatory cytokines like TNF-α and IL-1β[2][5][8], modulation of immune cell populations (reducing NK cells while boosting T cells)[2], downregulation of prostaglandin receptors in synovial tissue[2], relief from acute/chronic soft tissue inflammation[2], protection against bone destruction via modulation of ephrinB2 signaling[6], and improvement in quality-of-life measures for patients with chronic pain syndromes. The formula typically contains multiple herbs such as Notopterygium root/rhizome (Qiang Huo), Turmeric rhizome (Jiang Huang), White Mulberry twig (Sang Zhi), Angelica sinensis root (Dang Gui), Acanthopanax cortex/bark (Hong Mao Wu Jia Pi), Pubescent angelica root (Du Huo), Large leaf gentian root (Qin Jiao), Frankincense resin (Ru Xiang), Costus/Vladimiria root (Chuan Mu Xiang), Ligusticum wallichii rhizome/rootstock/Chuanxiong Rhizoma/Chuan Xiong, Cinnamon twig/Ramulus Cinnamomi/Gui Zhi, Chinese licorice/honey-fried Glycyrrhizae Radix Preparata/Zhi Gan Cao among others; specific composition may vary by manufacturer or modification[1][7]. It is administered orally in forms such as decoctions/granules/tablets/capsules.

Brand names
Juan Bi FormulaJuan Bi TangJuanbi PillJuanbi capsule
Other names
蠲痹汤Remitting Bi DecoctionJuan Bi TangJBT
02

Targets

NF-κBFOS (Activator Protein 1)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on juanbi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on juanbi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call